Navigation Links
Mouse brain cells rapidly recover after Alzheimer's plaques are cleared

condition. The second, developed by scientists at Washington University, causes some of the mouse brain cells to produce a dye that allowed Brendza to obtain detailed images of nerve cell branches. To correlate brain cell changes with plaque development, Brendza injected another dye, developed by scientists at the University of Pittsburgh, that temporarily sticks to amyloid. He showed that as the plaques appeared, nearby branches of nerve cells developed bumps and swellings. "If you look under the electron microscope at these swellings, they are filled with abnormal amounts of different types of cellular parts known as organelles," Holtzman explains. "Normally any given segment of a nerve cell branch would have only very small amounts of these organelles." Nerve cells move organelles along their branches as a part of their regular function. Holtzman suspects that this transport breaks down in the mice, leading to pileups that become swellings. Scientists have previously demonstrated that such swellings make it difficult or impossible for nerve-cell branches to send signals. After showing that the swellings were mostly stable in number and size over the course of three to seven days, Brendza injected Abeta antibodies directly onto the surface of the mouse brains. In the region of the injection, the antibodies cleared the plaques, confirming earlier research results. Then Brendza closely monitored the swellings for three days. "We thought that clearing the plaques would halt the progression of the damage--stop the development of new swellings," says Brendza. "But what we saw was much more striking: in just three days, there were 20 to 25 percent reductions in the number or size of the existing swellings." The nerve cells' rapid ability to regain normal structure has Holtzman and Brendza wondering if the nerve cells are constantly trying to restore their normal structure. If so, that recuperative effort must somehow be countered on an ongoing basis by the effects of th
'"/>

Source:Washington University School of Medicine


Page: 1 2 3

Related biology news :

1. Mouse brain tumors mimic those in human genetic disorder
2. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
3. Mouse gene shows new mechanism behind cardiac infarction in man
4. Mouse with designer liver has enhanced glucose tolerance, insulin response
5. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
6. Mouse genome much more complex than expected
7. Mouse study: New muscle-building agent beats all previous ones
8. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
9. Mouse to man: The story of chromosomes
10. Mouse mimics chronic leukemia, will aid drug development
11. Mouse study reveals new clues about virulence of 1918 influenza virus

Post Your Comments:
(Date:11/24/2009)...eries from collapsing have been true life-savers. ...eeded -- once the arteries are strengthened, they ...ice but to leave them in place. , Prof. Meital Z...omedical Engineering has developed a new patent-pe...,re needed, then dissolves. , "Our new composite...
(Date:11/24/2009)...secrets of the earth,s history locked in its icy d...tle information on the environments that have been.... Now, a team of researchers from nine institution...$10 million dollars by the National Science Founda...rally. These scientists will drill through the Wes...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A Milestone of Opportunity for VNUS Medical Technologies 48130 1A Milestone of Opportunity for VNUS Medical Technologies 48130 2A Milestone of Opportunity for VNUS Medical Technologies 48130 3Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 1Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 2Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 3Forterus Inc Announces Free Outpatient Treatment to Military Veterans Back from War Zones 48129 1Forterus Inc Announces Free Outpatient Treatment to Military Veterans Back from War Zones 48129 2
...unisia, supported by the European Commission, high... health in countries bordering the Mediterranean S...rtance of Euro-Mediterranean partnerships in order...e sciences ?in particular following the mapping of...rove scientific knowledge and approaches to improv...
... radiotherapy, on a cellular scale. Antibodies cou..., bind to and kill cancerous cells. Provided that ...ce between normal and cancerous cells; this is not... for lymphoma that takes a fraction of the time of...caused tumors to shrink in 95 percent of patients,...
...called CD14 binds to substances liberated from the...nisms. In a report published in the Journal of Bio...heir elucidation of three-dimensional structure of...d to certain bacterial products. , The research ap...ssue of the Journal of Biological Chemistry, an Am...
Other Biology News:Measuring the impact of post-genomics on Mediterranean populations 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 3Scientists solve structure of key protein in innate immune response 2
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutical...ice (PTO) has allowed the patent application for,i..., NOD technology is a highly efficient ap...o-adhesive nano-particles to enable oral delivery ... technology is a platform technology,that can be a...
(Date:11/24/2009)...HAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy...istration (SFDA) has approved the,investigational ...oject,(Nodlin), an innovative insulin formulation ...y to initiate its first phase I clinical study. ,...high blood glucose and poor,metabolism. The compli...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... CITY, New Jersey, November 26, Rosetta Genomics (...third quarter financial results on December 5, 200...will host a conference call with a,simultaneous we...Friday,December 5. , To access the live conf...al 1-866-966-5335; international participants may ...
...E, Nov. 26 Spectrum,Pharmaceuticals, Inc. (Nasdaq...CTIC )(MTA: CTIC) announced today they have entere...nture, RIT Oncology LLC, to commercialize and,deve... United States.,ZEVALIN, a radioimmunotherapeutic ...by Cell Therapeutics, Inc. (CTI) for the treatment...
...Equels, President and Managing,Director of the Equ...ectors,for Hemispherx BioPharma, Inc. (Amex: HEB... engaged in the manufacture and clinical developme... and immune-based disorders. , Equels, legal...r emphasis,on civil racketeering, business torts a...
Other Biology Technology:Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 3Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 4Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 5Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 6Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 7Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 8Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3
Stirbar, Trans-Blot Plus cell from Bio-Rad
Super Cooling Coil, Trans-Blot cell from Bio-Rad
Criterion Staining and Blotting Trays, with lids, 12 from Bio-Rad
...ting a wide range of next-generation features into...andard for flexible laboratory solutions. It puts ...ng, dilution, dispensing, and integrations into a...exible as it is efficient and economical. The Biom...
Biology Products: